The Effect of NK Cell Activation by Tumor Cells on Antigen-Specific Antibody Responses

Crystal Y. Koh, Dorothy Yuan

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In addition to mediating direct cytotoxicity, NK cells can exert regulatory effects on specific immune responses. For example, injection of poly (I:C) can alter specific Ab responses, which is attributable to the production of IFN-γ by NK cells. To test whether direct activation of NK cells can exert the same effect, we have injected, at the same time as Ag challenge, BCL1-C11 tumor cells, which are highly effective inducers of IFN-γ production by NK cells. The results show a specific enhancement of the IgG2a response, which does not occur with a tumor (70Z/3) that does not induce IFN-γ production. This enhancement is NK cell and IL-12 dependent. However, BCL1-C11 cells cannot directly induce IL-12 production in peritoneal exudate cells (PECs). On the other hand, PECs from tumor-treated mice produce IL-12 in response to LPS, suggesting that they are primed in vivo. Furthermore, the IL-12 production is NK cell and IFN-γ dependent. These results indicate that if tumor cells can directly activate NK cells to produce IFN-γ, this cytokine initiates an amplification loop by activating macrophages to produce IL-12, which in turn activates NK cells further, resulting in the alteration of the isotype distribution of specific Ab responses. Production of the appropriate Ab isotype should enhance Ab-dependent cellular cytotoxicity against targets mediated by NK cells, implicating their role(s) in the specific immune response as well as the initial nonspecific phase.

Original languageEnglish
Pages (from-to)4745-4752
Number of pages8
JournalJournal of Immunology
Volume159
Issue number10
Publication statusPublished - Nov 15 1997

Fingerprint

Natural Killer Cells
Antibody Formation
Antigens
Interleukin-12
Neoplasms
Exudates and Transudates
Macrophages
Cytokines
Injections

ASJC Scopus subject areas

  • Immunology

Cite this

The Effect of NK Cell Activation by Tumor Cells on Antigen-Specific Antibody Responses. / Koh, Crystal Y.; Yuan, Dorothy.

In: Journal of Immunology, Vol. 159, No. 10, 15.11.1997, p. 4745-4752.

Research output: Contribution to journalArticle

@article{e6a3ead629f84ee98cf457f8542f6e8a,
title = "The Effect of NK Cell Activation by Tumor Cells on Antigen-Specific Antibody Responses",
abstract = "In addition to mediating direct cytotoxicity, NK cells can exert regulatory effects on specific immune responses. For example, injection of poly (I:C) can alter specific Ab responses, which is attributable to the production of IFN-γ by NK cells. To test whether direct activation of NK cells can exert the same effect, we have injected, at the same time as Ag challenge, BCL1-C11 tumor cells, which are highly effective inducers of IFN-γ production by NK cells. The results show a specific enhancement of the IgG2a response, which does not occur with a tumor (70Z/3) that does not induce IFN-γ production. This enhancement is NK cell and IL-12 dependent. However, BCL1-C11 cells cannot directly induce IL-12 production in peritoneal exudate cells (PECs). On the other hand, PECs from tumor-treated mice produce IL-12 in response to LPS, suggesting that they are primed in vivo. Furthermore, the IL-12 production is NK cell and IFN-γ dependent. These results indicate that if tumor cells can directly activate NK cells to produce IFN-γ, this cytokine initiates an amplification loop by activating macrophages to produce IL-12, which in turn activates NK cells further, resulting in the alteration of the isotype distribution of specific Ab responses. Production of the appropriate Ab isotype should enhance Ab-dependent cellular cytotoxicity against targets mediated by NK cells, implicating their role(s) in the specific immune response as well as the initial nonspecific phase.",
author = "Koh, {Crystal Y.} and Dorothy Yuan",
year = "1997",
month = "11",
day = "15",
language = "English",
volume = "159",
pages = "4745--4752",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - The Effect of NK Cell Activation by Tumor Cells on Antigen-Specific Antibody Responses

AU - Koh, Crystal Y.

AU - Yuan, Dorothy

PY - 1997/11/15

Y1 - 1997/11/15

N2 - In addition to mediating direct cytotoxicity, NK cells can exert regulatory effects on specific immune responses. For example, injection of poly (I:C) can alter specific Ab responses, which is attributable to the production of IFN-γ by NK cells. To test whether direct activation of NK cells can exert the same effect, we have injected, at the same time as Ag challenge, BCL1-C11 tumor cells, which are highly effective inducers of IFN-γ production by NK cells. The results show a specific enhancement of the IgG2a response, which does not occur with a tumor (70Z/3) that does not induce IFN-γ production. This enhancement is NK cell and IL-12 dependent. However, BCL1-C11 cells cannot directly induce IL-12 production in peritoneal exudate cells (PECs). On the other hand, PECs from tumor-treated mice produce IL-12 in response to LPS, suggesting that they are primed in vivo. Furthermore, the IL-12 production is NK cell and IFN-γ dependent. These results indicate that if tumor cells can directly activate NK cells to produce IFN-γ, this cytokine initiates an amplification loop by activating macrophages to produce IL-12, which in turn activates NK cells further, resulting in the alteration of the isotype distribution of specific Ab responses. Production of the appropriate Ab isotype should enhance Ab-dependent cellular cytotoxicity against targets mediated by NK cells, implicating their role(s) in the specific immune response as well as the initial nonspecific phase.

AB - In addition to mediating direct cytotoxicity, NK cells can exert regulatory effects on specific immune responses. For example, injection of poly (I:C) can alter specific Ab responses, which is attributable to the production of IFN-γ by NK cells. To test whether direct activation of NK cells can exert the same effect, we have injected, at the same time as Ag challenge, BCL1-C11 tumor cells, which are highly effective inducers of IFN-γ production by NK cells. The results show a specific enhancement of the IgG2a response, which does not occur with a tumor (70Z/3) that does not induce IFN-γ production. This enhancement is NK cell and IL-12 dependent. However, BCL1-C11 cells cannot directly induce IL-12 production in peritoneal exudate cells (PECs). On the other hand, PECs from tumor-treated mice produce IL-12 in response to LPS, suggesting that they are primed in vivo. Furthermore, the IL-12 production is NK cell and IFN-γ dependent. These results indicate that if tumor cells can directly activate NK cells to produce IFN-γ, this cytokine initiates an amplification loop by activating macrophages to produce IL-12, which in turn activates NK cells further, resulting in the alteration of the isotype distribution of specific Ab responses. Production of the appropriate Ab isotype should enhance Ab-dependent cellular cytotoxicity against targets mediated by NK cells, implicating their role(s) in the specific immune response as well as the initial nonspecific phase.

UR - http://www.scopus.com/inward/record.url?scp=0031573226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031573226&partnerID=8YFLogxK

M3 - Article

VL - 159

SP - 4745

EP - 4752

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -